| 2024年中报 | 2023年年报 | 2023年中报 | 2022年年报 | 2022年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 处方药类(元) | 235,849,737.96 | 663,884,422.30 | 344,360,173.27 | 744,757,156.29 | 343,799,754.00 |
| 非处方药类(元) | 1,725,109,073.76 | 3,050,072,545.59 | 1,646,417,842.53 | 2,617,708,302.19 | 1,335,576,786.06 |
| 保健品及其他(元) | 193,952,127.85 | 649,938,724.87 | 284,818,304.19 | 409,362,222.39 | 178,605,954.03 |
| 营业成本(元) | |||||
| 处方药类(元) | 118,831,829.22 | 244,214,394.15 | 103,408,092.06 | 246,238,020.87 | 116,549,011.10 |
| 非处方药类(元) | 430,333,819.13 | 863,287,475.30 | 437,016,384.15 | 792,980,089.70 | 380,190,949.33 |
| 保健品及其他(元) | 114,549,972.21 | 407,648,035.42 | 183,976,103.91 | 283,611,917.90 | 115,226,101.27 |
| 毛利(元) | |||||
| 处方药类(元) | 117,017,908.74 | 419,670,028.15 | 240,952,081.21 | 498,519,135.42 | 227,250,742.90 |
| 非处方药类(元) | 1,294,775,254.63 | 2,186,785,070.29 | 1,209,401,458.38 | 1,824,728,212.49 | 955,385,836.73 |
| 保健品及其他(元) | 79,402,155.64 | 242,290,689.45 | 100,842,200.28 | 125,750,304.49 | 63,379,852.76 |
| 毛利率(%) | |||||
| 处方药类(%) | 49.62 | 63.21 | 69.97 | 66.94 | 66.10 |
| 非处方药类(%) | 75.05 | 71.70 | 73.46 | 69.71 | 71.53 |
| 保健品及其他(%) | 40.94 | 37.28 | 35.41 | 30.72 | 35.49 |
| 收入构成(%) | |||||
| 处方药类(%) | 10.94 | 15.21 | 15.13 | 19.75 | 18.50 |
| 非处方药类(%) | 80.05 | 69.89 | 72.35 | 69.40 | 71.88 |
| 保健品及其他(%) | 9.00 | 14.89 | 12.52 | 10.85 | 9.61 |
| 毛利构成(%) | |||||
| 处方药类(%) | 7.85 | 14.73 | 15.53 | 20.36 | 18.24 |
| 非处方药类(%) | 86.83 | 76.76 | 77.97 | 74.51 | 76.68 |
| 保健品及其他(%) | 5.32 | 8.51 | 6.50 | 5.13 | 5.09 |